Information For Authors
We invite scholars, clinicians, and researchers across all fields of biomedicine and health sciences to contribute original and high-quality manuscripts to Emerging Frontiers in Translational Biomedicine and Health Sciences (EFTBHS). The journal publishes work that bridges discovery and application, emphasizing studies with clear translational relevance, methodological rigor, and ethical integrity.
Interested in submitting to this journal?
We recommend that you first review the About the Journal page, which outlines the journal’s section policies, Aims and Scope, and Author Guidelines. These resources provide detailed information on article types, submission requirements, referencing format, and ethical standards. Authors are also encouraged to familiarize themselves with the Peer Review Policy to understand the evaluation criteria used by reviewers and editors.
Authors must register with the journal prior to submitting a manuscript. New users can create an account using the Register link at the top of the homepage, while returning authors may simply log in and begin the five-step online submission process. The system guides contributors through each stage, from uploading the manuscript and metadata to final confirmation. Submissions should include all required documents such as ethical statements, funding acknowledgments, and supplementary files where applicable.
All manuscripts undergo an initial editorial screening followed by a double-blind peer review conducted by at least two independent experts. Reviewers evaluate the scientific quality, originality, clarity, and significance of the work. The editorial decision—accept, revise, or reject—is based on the reviewers’ recommendations, adherence to ethical standards, and the contribution to translational knowledge and clinical impact.
EFTBHS maintains a transparent and ethical publishing environment consistent with the Committee on Publication Ethics (COPE) Core Practices. Authors must ensure that all co-authors have approved the final version of the manuscript and agree with its submission. Plagiarism, data fabrication, and duplicate publication are strictly prohibited, and all submissions are screened using reliable plagiarism detection tools before review.
To enhance visibility and accessibility, all accepted articles are published under the Creative Commons Attribution (CC BY 4.0) license. Authors retain copyright while granting the journal the right of first publication, ensuring global access and citation of their work.
Prospective authors are encouraged to contact the editorial office for clarification regarding manuscript suitability, formatting requirements, or ethical considerations. Publishing with EFTBHS ensures that your research reaches a diverse global audience while contributing to the advancement of translational science and improved health outcomes.